ABACUS BIOSCIENCE, INC.
4Patents
4Active
4Granted
49Portfolio score
Filing activity: Nov 22, 2016 → Jul 1, 2022
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11389532B2 | Therapeutic vaccine for Hepatitis b virus (HBV) using the HBV PreS1 and/or PreS2, and/or s-HBsAg regions of the HBV envelope protein | Chemistry; Metallurgy | 1 | Active |
| US12285482B2 | Therapeutic vaccine for Hepatitis B virus (HBV) using the HBV PreS1 and/or PreS2, and/or S-HBsAg regions of the HBV envelope protein | Chemistry; Metallurgy | 0 | Active |
| US11883488B2 | Therapeutic vaccine for Hepatitis B virus (HBV) using the HBV core antigen | Chemistry; Metallurgy | 0 | Active |
| US11324819B2 | Therapeutic vaccine for Hepatitis b virus (HBV) using the HBV core antigen | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.